Sign in

CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company

Damora Therapeutics, Inc.

Sign in to watch
Ticker
DMRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
371957007
Phone
(781) 281-9020
Business address
100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
Former names
Galecto, Inc., Galecto Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 8-K Event Executive or director change · Regulation FD disclosure
  7. S-8 Other Securities Offered to Employees in Benefit Plans
  8. 10-K Report Annual Report
  9. 8-K Event Results of operations · Bylaws or fiscal year change · Regulation FD disclosure
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. 4 Option exercise Director acquired 129,000 shares (option exercise)
  14. 4 Option exercise Director acquired 8,713,000 shares (option exercise)
  15. SCHEDULE 13D/A Stake Beneficial Ownership Report
  16. 8-K Event Material agreement
  17. 424B5 Offering Prospectus
  18. 424B5 Offering Prospectus
  19. S-3ASR Offering Registration Statement
  20. 8-K Event Executive or director change · Bylaws or fiscal year change · Other events

Page 3 of 18 · 353 filings